Mouse adenovirus will be developed as a model system for molecular genetic studies of viral pathogenesis. The mechanisms by which the species-specific human adenoviruses cause disease are poorly understood, in part due to the lack of an animal model. The molecular biology of mouse adenovirus will be characterized in order to utilize an in vitro mutagenic approach to correlate gene functions with adenovirus pathogenesis. Molecular clones of mouse adenoviral DNA will be used to examine the expression of mouse adenoviral genes in infected mouse L cells. Viral RNAs will be characterized by hybridization analyses, and the RNA transcription map will be determined and compared to that of the human adenoviruses. This will allow rational design of mutagenic strategies to investigate viral genes in a transcription unit thought to be involved in pathogenesis. Initially, viral mutants will be isolated which lack a restriction enzyme site. These mutants, which will be likely to have deletion and/or substitution of nucleic acid sequences, will be characterized with respect to their properties in both cell culture and in vivo infections. As transcription map information becomes available, site-directed viral mutants will be constructed, by obtaining mutations in plasmid DNA and subsequent transfer of the mutations to viral DNA. Pathogenesis of wild-type and mutants of mouse adenovirus will be examined with respect to susceptibility of several inbred strains of mice and presence of virus and viral nucleic acids in various tissues of infected mice. Several human adenovirus genes, which are not required for viral growth in cell culture, have been postulated to be important in vivo in pathogenesis. Using the mouse adenovirus as a model, it should be possible to correlate the function of such genes with adenovirus pathogenesis. Thus, these molecular and biological studies will yield information on mechanisms by which adenoviruses cause disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI023762-02
Application #
3136135
Study Section
Virology Study Section (VR)
Project Start
1987-07-01
Project End
1990-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
2
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Georgia
Department
Type
Schools of Arts and Sciences
DUNS #
City
Athens
State
GA
Country
United States
Zip Code
30602
Castro-Jorge, Luiza A; Pretto, Carla D; Smith, Asa B et al. (2017) A Protective Role for Interleukin-1 Signaling during Mouse Adenovirus Type 1-Induced Encephalitis. J Virol 91:
Ashley, Shanna L; Pretto, Carla D; Stier, Matthew T et al. (2017) Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1. J Virol 91:
Daugherty, Matthew D; Schaller, Aaron M; Geballe, Adam P et al. (2016) Evolution-guided functional analyses reveal diverse antiviral specificities encoded by IFIT1 genes in mammals. Elife 5:
Gounder, Anshu P; Myers, Nicolle D; Treuting, Piper M et al. (2016) Defensins Potentiate a Neutralizing Antibody Response to Enteric Viral Infection. PLoS Pathog 12:e1005474
Tirumuru, Nagaraja; Pretto, Carla D; Castro Jorge, Luiza A et al. (2016) Mouse Adenovirus Type 1 Early Region 1A Effects on the Blood-Brain Barrier. mSphere 1:
Spindler, Katherine R; Hsu, Tien-Huei (2012) Viral disruption of the blood-brain barrier. Trends Microbiol 20:282-90
Hsu, Tien-Huei; Althaus, Irene W; Foreman, Oded et al. (2012) Contribution of a single host genetic locus to mouse adenovirus type 1 infection and encephalitis. MBio 3:
Robinson, Michael; Li, Betty; Ge, Ying et al. (2009) Novel immunocompetent murine tumor model for evaluation of conditionally replication-competent (oncolytic) murine adenoviral vectors. J Virol 83:3450-62
Raman, Sharmila; Hsu, Tien-Huei; Ashley, Shanna L et al. (2009) Usage of integrin and heparan sulfate as receptors for mouse adenovirus type 1. J Virol 83:2831-8
Gralinski, Lisa E; Ashley, Shanna L; Dixon, Shandee D et al. (2009) Mouse adenovirus type 1-induced breakdown of the blood-brain barrier. J Virol 83:9398-410

Showing the most recent 10 out of 40 publications